The transaction was completed through a share for debt transaction on 8 March, which stood at nearly 7.7% of the issued and outstanding common shares of Nighthawk on the day of transaction.
After closing of the transaction, the acquirer will have and control of an aggregate of 26,737,959 common shares and 2,839,857 convertible securities of Nighthawk, representing approximately 14.4% of the issued and outstanding common shares.
This transaction was effected for investment purposes and the acquirer and its joint actor, Cudney, could increase or decrease their investments in Nighthawk at any time, or continue to maintain their current investment position.
Canada-based Northfield Capital aims to boost the growth and development of its investment partners and to build long-term value for its shareholders through strategic investment plan.
